José Alfón

794 total citations
28 papers, 490 citations indexed

About

José Alfón is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, José Alfón has authored 28 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in José Alfón's work include Autophagy in Disease and Therapy (7 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Lipoproteins and Cardiovascular Health (5 papers). José Alfón is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Endoplasmic Reticulum Stress and Disease (5 papers) and Lipoproteins and Cardiovascular Health (5 papers). José Alfón collaborates with scholars based in Spain, United States and France. José Alfón's co-authors include Lina Badimón, M. Berrozpe, T. Royo, Manuel Merlos, José Martínez‐González, Xavier García–Moll, Joan Francesc Guasch, Javier Bartrolí, Fernando L. Cavalcanti and Carmen Almansa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

José Alfón

27 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José Alfón Spain	10	163	119	110	99	91	28	490
Kaori Endo‐Umeda Japan	14	195 1.2×	231 1.9×	61 0.6×	165 1.7×	77 0.8×	24	591
Eva Sánchez-Galán Spain	7	85 0.5×	132 1.1×	15 0.1×	119 1.2×	48 0.5×	9	408
Graziella Malaponte Italy	9	56 0.3×	241 2.0×	47 0.4×	69 0.7×	35 0.4×	10	481
Xijun Liu China	15	79 0.5×	340 2.9×	19 0.2×	70 0.7×	129 1.4×	27	629
C. Dachet France	12	321 2.0×	183 1.5×	18 0.2×	80 0.8×	62 0.7×	21	649
P. Roma Italy	17	276 1.7×	284 2.4×	20 0.2×	171 1.7×	70 0.8×	25	702
Masahide Nakajima Japan	12	50 0.3×	240 2.0×	88 0.8×	69 0.7×	13 0.1×	28	438
Michele L. Kus United Kingdom	8	75 0.5×	219 1.8×	26 0.2×	177 1.8×	22 0.2×	9	571
Jin‐Ling Huo China	11	38 0.2×	210 1.8×	60 0.5×	80 0.8×	31 0.3×	19	486

Countries citing papers authored by José Alfón

Since Specialization

Citations

This map shows the geographic impact of José Alfón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Alfón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Alfón more than expected).

Fields of papers citing papers by José Alfón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Alfón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Alfón. The network helps show where José Alfón may publish in the future.

Co-authorship network of co-authors of José Alfón

This figure shows the co-authorship network connecting the top 25 collaborators of José Alfón. A scholar is included among the top collaborators of José Alfón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Alfón. José Alfón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bosch‐Barrera, Joaquim, Purificación Estévez-García, Paloma Martín-Martorell, et al.. (2025). ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer. Lung Cancer. 201. 108105–108105. 3 indexed citations

Li, Rong, Y. Runglodvatana, Kyung‐Yul Lee, et al.. (2024). OA16.05 Trastuzumab Deruxtecan Monotherapy in Pretreated HER2-overexpressing Nonsquamous Non-Small Cell Lung Cancer: DESTINY-Lung03 Part 1. Journal of Thoracic Oncology. 19(10). S46–S47. 6 indexed citations

Bosch‐Barrera, Joaquim, Teresa Morán, Purificación Estévez-García, et al.. (2023). Phase 2 clinical trial of the proautophagic drug ABTL0812 combined with paclitaxel and carboplatin in first-line patients with advanced squamous non-small cell lung carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 9059–9059. 1 indexed citations

Mancini, Andrea, Alessandro Colapietro, Loredana Cristiano, et al.. (2022). Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models. Frontiers in Oncology. 12. 943064–943064. 7 indexed citations

Bosch‐Barrera, Joaquim, Teresa Morán, Purificación Estévez-García, et al.. (2021). MA01.06 Phase 2 of Pro-Autophagic Drug ABTL0812 in Combination With First-Line Paclitaxel and Carboplatin in IIIb/IV Squamous NSCLC. Journal of Thoracic Oncology. 16(3). S130–S131. 1 indexed citations

Vidal, Laura, Iván Victoria, Lydia Gaba, et al.. (2021). A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours. European Journal of Cancer. 146. 87–94. 18 indexed citations

Soriano, Aroa, Carlos Jiménez, Tatiana Erazo, et al.. (2020). The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis. Cell Death and Disease. 11(9). 773–773. 6 indexed citations

Léary, Alexandra, Purificación Estévez-García, Renaud Sabatier, et al.. (2020). 864P Phase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer. Annals of Oncology. 31. S639–S640. 1 indexed citations

Erazo, Tatiana, Mar Lorente, Patricia Fernández‐Nogueira, et al.. (2015). The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase. Clinical Cancer Research. 22(10). 2508–2519. 59 indexed citations

10.

Alfón, José, Carolina Salcedo, Alberto Fernández, et al.. (2011). Efficacy Of UR-63325, A New Histamine H4 Receptor Antagonist, In House Dust Mite-Induced Mouse Asthma Models. A1302–A1302. 3 indexed citations

11.

Alfón, José, Noelia Ardanaz, B. Gil-Torregrosa, et al.. (2009). UR-60427, a novel H4 receptor-inverse agonist that shows good efficacy in a rat asthma model. Inflammation Research. 59(S2). 199–200. 5 indexed citations

12.

Cortijo, Julio, María‐Jesús Sanz, José Luis González Montesinos, et al.. (2006). A small molecule, orally active, α₄β₁/α₄β₇ dual antagonist reduces leukocyte infiltration and airway hyper‐responsiveness in an experimental model of allergic asthma in Brown Norway rats. British Journal of Pharmacology. 147(6). 661–670. 30 indexed citations

13.

Alfón, José, et al.. (2001). Alternative Binding Assay of GP IIb/IIIa Antagonists With a Nonradioactive Labeling Method of Platelets. Thrombosis Research. 102(3). 247–253. 1 indexed citations

14.

Royo, T., José Alfón, M. Berrozpe, & Lina Badimón. (2000). Effect of gemfibrozil on peripheral atherosclerosis and platelet activation in a pig model of hyperlipidemia. European Journal of Clinical Investigation. 30(10). 843–852. 14 indexed citations

15.

Alfón, José, T. Royo, Xavier García–Moll, & Lina Badimón. (1999). Platelet Deposition on Eroded Vessel Walls at a Stenotic Shear Rate Is Inhibited by Lipid-Lowering Treatment With Atorvastatin. Arteriosclerosis Thrombosis and Vascular Biology. 19(7). 1812–1817. 47 indexed citations

16.

Alfón, José, Joan Francesc Guasch, M. Berrozpe, & Lina Badimón. (1999). Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitors. Atherosclerosis. 145(2). 325–331. 47 indexed citations

17.

Alfón, José, et al.. (1998). Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk. Atherosclerosis. 136(2). 333–345. 21 indexed citations

18.

Alfón, José, et al.. (1994). Pharmacodynamics of Phenobarbital Anesthesia and Pentylenetetrazol-Induced Maximal Seizures in a Rat Model of Neoplastic Spinal Cord Compression. Pharmaceutical Research. 11(4). 536–540. 1 indexed citations

19.

Alfón, José, et al.. (1994). The Effect of Immunosuppression by Total-Body Irradiation on the Pharmacodynamics of Centrally Active Drugs in Rats. Pharmaceutical Research. 11(5). 704–708. 2 indexed citations

20.

Hoffman, Amnon & José Alfón. (1992). High-Dose Methotrexate Does Not Affect the Pharmacodynamics of Phenobarbital Hypnotic Action but Decreases the Central Nervous System (CNS) Sensitivity to Pentylenetetrazol-Induced Maximal Seizures in Rats. Pharmaceutical Research. 9(10). 1295–1298. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact